Jan Nilsson
201 – 250 of 294
- show: 50
- |
- sort: year (new to old)
Close
Embed this list
<iframe src=" "
width=" "
height=" "
allowtransparency="true"
frameborder="0">
</iframe>
- 2010
-
Mark
Weak associations between human leucocyte antigen genotype and acute myocardial infarction.
(
- Contribution to journal › Article
-
Mark
Innate immunity in atherosclerosis
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
A Method to Measure Shear Strain with High Spatial Resolution in the Arterial Wall Non-Invasively in vivo by Tracking Zero-Crossings of B-Mode Intensity Gradients
2010) p.491-494(
- Chapter in Book/Report/Conference proceeding › Paper in conference proceeding
-
Mark
CD8+ T cell activation predominate early immune responses to hypercholesterolemia in Apoe-/- mice.
(
- Contribution to journal › Article
-
Mark
The B cell in Atherosclerosis: Teaming Up with the Bad Guys?
(
- Contribution to journal › Article
-
Mark
Vascular cellular adhesion molecule-1 (VCAM-1) expression in mice retinal vessels is affected by both hyperglycemia and hyperlipidemia.
(
- Contribution to journal › Article
-
Mark
Cardiovascular and cancer mortality in very elderly post-myocardial infarction patients receiving statin treatment.
(
- Contribution to journal › Article
-
Mark
Nuclear Factor of Activated T Cells Regulates Osteopontin Expression in Arterial Smooth Muscle in Response to Diabetes-Induced Hyperglycemia.
(
- Contribution to journal › Article
- 2009
-
Mark
Vaccination against atherosclerosis? Induction of atheroprotective immunity
(
- Contribution to journal › Scientific review
-
Mark
Associations between autoantibodies against apolipoprotein B-100 peptides and vascular complications in patients with type 2 diabetes.
(
- Contribution to journal › Article
-
Mark
Shifting to new targets in pharmacological prevention of cardiovascular diseases
(
- Contribution to journal › Debate/Note/Editorial
-
Mark
Diet-Induced Hyperlipidemia Activates Myd88-Dependent Innate Immune Signaling Resulting In Increased Leukocyte Rolling In Vivo
(
- Contribution to journal › Published meeting abstract
-
Mark
Evidence Of A Role Of T Regulatory Cells Mediating Atheroprotection By APO B 100 Peptide Immunization
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.885-885(
- Contribution to journal › Published meeting abstract
-
Mark
Apob-100 Peptide Immunization Reduce Macrophage Plaque Infiltration In Apobec1-/- Ldlr-/- Mice With Advanced Atherosclerotic Lesions
(
- Contribution to journal › Published meeting abstract
-
Mark
FCGAMMARIIB Inhibits The Development Of Atherosclerosis In Mice
(
- Contribution to journal › Published meeting abstract
-
Mark
Associations Between Human Leukocyte Antigen (HLA) Genotype And Acute Myocardial Infarction
2009) 15th International Symposium on Atherosclerosis In Atherosclerosis Supplements 10(2). p.953-953(
- Contribution to journal › Published meeting abstract
-
Mark
Tumor necrosis factor-alpha does not mediate diabetes-induced vascular inflammation in mice.
(
- Contribution to journal › Article
-
Mark
Regulatory T cells and the control of modified lipoprotein autoimmunity-driven atherosclerosis.
(
- Contribution to journal › Article
-
Mark
Identification of the target for therapeutic recombinant anti-apoB-100 peptide antibodies in human atherosclerotic lesions.
(
- Contribution to journal › Article
-
Mark
Atheroprotective Effects of Alum Are Associated With Capture of Oxidized LDL Antigens and Activation of Regulatory T Cells.
(
- Contribution to journal › Article
-
Mark
Vaccines modulating lipoprotein autoimmunity as a possible future therapy for cardiovascular disease.
(
- Contribution to journal › Article
- 2008
-
Mark
Evaluation of the T cell response to apolipoprotein B100 (ApoB100): A new opportunity for immunotherapy against atherosclerosis
(
- Contribution to journal › Published meeting abstract
-
Mark
Interleukin-1 beta and tumour necrosis factor-alpha impede neutral lipid turnover in macrophage-derived foam cells
(
- Contribution to journal › Article
-
Mark
Autoantibodies against modified apolipoprotein B-100 in relation to low-density lipoprotein size and the metabolic syndrome in otherwise healthy men
(
- Contribution to journal › Article
-
Mark
Athero-protective effects of a human apoB-100 related peptide vaccine in apoE-/- mice are modulated by peptide dose and time of initiation of high fat diet
2008) American College of Cardiology 57th Annual Scientific Session In Journal of the American College of Cardiology 51(10, Suppl. 1). p.343-343(
- Contribution to journal › Published meeting abstract
-
Mark
Inflammation and immunity in diabetic vascular complications.
(
- Contribution to journal › Article
-
Mark
Cystatin C and cathepsins in cardiovascular disease.
(
- Contribution to journal › Article
-
Mark
High plasma concentrations of autoantibodies against native peptide 210 of apoB-100 are related to less coronary atherosclerosis and lower risk of myocardial infarction
(
- Contribution to journal › Article
-
Mark
Nanomolar concentrations of lysophosphatidylcholine recruit monocytes and induce pro-inflammatory cytokine production in macrophages.
(
- Contribution to journal › Article
- 2007
-
Mark
Oxidized LDL antibodies in treatment and risk assessment of atherosclerosis and associated cardiovascular disease.
(
- Contribution to journal › Scientific review
-
Mark
Active and passive immunization for atherosclerosis
(
- Contribution to journal › Scientific review
-
Mark
Autoantibody against the amino acid sequence 661-680 in apo B-100 is associated with decreased carotid stenosis and cardiovascular events.
2007) In Atherosclerosis(
- Contribution to journal › Article
-
Mark
Inhibition of injury-induced arterial remodelling and carotid atherosclerosis by recombinant human antibodies against aldehyde-modified apoB-100.
(
- Contribution to journal › Article
-
Mark
Medial Expression of TNF-α and TNF Receptors Precedes the Development of Atherosclerotic Lesions in Apolipoprotein E/LDL Receptor Double Knockout Mice
(
- Contribution to journal › Article
-
Mark
Recombinant antibodies to an oxidized low-density lipoprotein epitope induce rapid regression of atherosclerosis in apobec-1(-/-)/low-density lipoprotein receptor(-/-) mice.
(
- Contribution to journal › Article
-
Mark
Simvastatin stimulates macrophage interleukin-1beta secretion through an isoprenylation-dependent mechanism.
(
- Contribution to journal › Article
-
Mark
Immunization for atherosclerosis
(
- Contribution to journal › Scientific review
-
Mark
Perilipin and adipophilin expression in lipid loaded macrophages
(
- Contribution to journal › Article
-
Mark
Association between IgM against an aldehyde-modified peptide in apolipoprotein B-100 and progression of carotid disease
(
- Contribution to journal › Article
-
Mark
Autoimmune responses against the apo B-100 LDL receptor-binding site protect against arterial accumulation of lipids in LDL receptor deficient mice.
(
- Contribution to journal › Article
-
Mark
Involvement of the CD1d-Natural killer T cell pathway in neointima formation after vascular injury
(
- Contribution to journal › Article
-
Mark
VLDL and atherosclerosis
2007)(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Immunomodulation of atherosclerosis
2007) p.371-382(
- Chapter in Book/Report/Conference proceeding › Book chapter
-
Mark
Pode a ultrasonografia carotídea reflectir a composição da placa aterosclerótica vulnerável?
(
- Contribution to journal › Article
- 2006
-
Mark
Identification of autoantibodies in human plasma recognizing an apoB-100 LDL receptor binding site peptide
(
- Contribution to journal › Article
-
Mark
Antibodies against oxidized low-density lipoprotein for the treatment of vulnerable plaques
(
- Contribution to journal › Article
-
Mark
Cytokine response to lipoprotein lipid loading in human monocyte-derived macrophages
(
- Contribution to journal › Article
-
Mark
Oxidized lipoprotein autoimmunity: an emerging drug target in cardiovascular disease
(
- Contribution to journal › Scientific review
-
Mark
Oxidants and antioxidants
2006) p.199-199(
- Chapter in Book/Report/Conference proceeding › Book chapter
- 2005
-
Mark
Absence of the protease inhibitor cystatin C in inflammatory cells results in larger plaque area in plaque regression of apoE-deficient mice.
(
- Contribution to journal › Article